Taiwan FDA registration 95b9e1826637085a9d403e41bcb6e2b8
Ganoderma lucidum ecstasy enzyme immune reagent
TW: 靈芝搖頭丸酵素免疫試劑
Taiwan·Risk Class 2·LIN-ZHI INTERNATIONAL, INC·Registered Oct 11, 2018 – Oct 11, 2028ActiveRegistration details
- Analysis ID
- 95b9e1826637085a9d403e41bcb6e2b8
- Customs Code
- DHA05603172701
Company information
- Manufacturer
- LIN-ZHI INTERNATIONAL, INC
- Manufacturer Country
- United States
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Product details
- Intended Use
- This product is used for the qualitative or semi-quantitative determination of ecstasy content in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Grade Material (Analysis Material Non-Analysis);; A.1150 Calibrated Products;; A.3610 甲基安非他命試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Oct 11, 2018
- Expiry Date
- Oct 11, 2028
About this record
Access comprehensive regulatory information for Ganoderma lucidum ecstasy enzyme immune reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 95b9e1826637085a9d403e41bcb6e2b8 and manufactured by LIN-ZHI INTERNATIONAL, INC. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices